Role of Serum Lactate Dehydrogenase Levels as a Marker in Diagnosis and Monitoring the Response to Treatment in Children with Megaloblastic Anemia
International Journal of Pharmaceutical Quality Assurance · 30.11.2026 · 17 (11)
DOI: 10.25258/ijpqa.17.11.14 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Pharmaceutical Quality Assurance, online erschienen am 30.11.2026. Verfasst von Ruksana Begum und 4 weiteren Autor:innen.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Background
Megaloblastic anemia is an important nutritional disorder in children, commonly caused by vitamin B12 and folate deficiencies. Serum lactate dehydrogenase (LDH) may be useful for assessing ineffective erythropoiesis and monitoring treatment response. Materials and Methods: This prospective observational study included 62 children aged 6 months to 18 years diagnosed with megaloblastic anemia at a tertiary pediatric hospital in Bengaluru. Serum LDH, hemoglobin, and mean corpuscular volume (MCV) were evaluated at baseline, day 14, and one month following treatment.
Results
Vitamin B12 deficiency was present in 90.3% of children, while 9.7% had mixed deficiency. Mean serum LDH decreased significantly from 592.27 ± 297.75 U/L at baseline to 243.06 ± 61.33 U/L on day 14 and 173.85 ± 34.36 U/L after one month (p=0.0005). Hemoglobin increased from 8.29 ± 1.30 to 9.31 ± 1.24 g/dL, while MCV decreased from 96.11 ± 11.12 to 81.02 ± 7.74 fL (p=0.0005). A significant negative correlation was observed between MCV and LDH on day 14 (r=−0.459, p=0.0002).
Conclusion
Serial serum LDH estimation may be a useful and accessible biochemical tool for monitoring early treatment response in children with megaloblastic anemia.
Zitieren
APA
Begum, R., Shinde, R., Reddy, S. C., R, P. A., & Shah, J. A. (2026). Role of Serum Lactate Dehydrogenase Levels as a Marker in Diagnosis and Monitoring the Response to Treatment in Children with Megaloblastic Anemia. International Journal of Pharmaceutical Quality Assurance, 17(11). https://doi.org/10.25258/ijpqa.17.11.14
Vancouver
Begum R, Shinde R, Reddy SC, R PA, Shah JA. Role of Serum Lactate Dehydrogenase Levels as a Marker in Diagnosis and Monitoring the Response to Treatment in Children with Megaloblastic Anemia. International Journal of Pharmaceutical Quality Assurance. 2026;17(11). doi:10.25258/ijpqa.17.11.14
BibTeX
@article{Begum2026,
author = {Begum, Ruksana and Shinde, Rajendra and Reddy, Sathvika Chandrashekara and R, Priyanka A. and Shah, Jacqueline A.},
title = {Role of Serum Lactate Dehydrogenase Levels as a Marker in Diagnosis and Monitoring the Response to Treatment in Children with Megaloblastic Anemia},
journal = {International Journal of Pharmaceutical Quality Assurance},
year = {2026},
volume = {17},
number = {11},
doi = {10.25258/ijpqa.17.11.14}
}
EUVIMED